July 21, 2020 5:23pm

As I stated this a.m., “Is the gain to be harvested?” It was …

Pre-open indications: 4 HITs and 2 MISS  

An “intelligence newspaper” for smart investing in the RegMed, gene and cell therapy sector.  Who is feeding your portfolio – profit from RMi’s analysis! Check the BOTTOM LINE … the facts are irrefutable and truth will make your portfolio profitable

Subscription is coming, it’s not a conscription but, an offer to join our collective of like-minded investors who make money and for those who read and don’t weep! 


The Dow closed UP +159.53 points (+0.60%), the S&P closed UP +5.46 points (+0.17%) while the NASDAQ closed DOWN -86.73 points (-0.81%)

 

Pre-open indication results: 4 HITs < Biostage (BSTG -$0.01 <was -$0.35> with 3,710 shares traded) – another day of manipulation?, CRISPR Therapeutics (CRSP -$1.54), bluebird bio (BLUE -$1.53), Pluristem (PSTI -$0.52)> 2 MISS < BioLife Solutions (BLFS +$0.32), Vericel (VCEL -$0.18)>

 

Henry’omics:

The Dow and S&P 500 traded higher as the Nasdaq got wiped on Tuesday as traders booked profits from the RegMed, cell and gene therapy sector – is it all about every two-session rotation – it seems.

It’s an algorithmic electronic machine playground …

 

RegMed/Cell and Gene therapy 35 covered equities’ Advance/Decline (A/D) lines: progressions and regressions …

  • Tuesday opened negative at 14/18 and 3 flats, stayed negative at the mid-day at 24/10 and 1 flat, closing negative at 10/24 and 1 flat;
  • Monday opened positive at 21/11 and 3 flats, stayed positive at the mid-day at 23/11 and 1 flat, closing positive at 24/10 and 1 flat;

 

Key metrics:

  • Sector volume was LOW with 6 of the 10-upside having higher than the 3-month average volume and 4 out of the 24-downside having higher than the 3-month average volume;
  • Tuesday’s percentage (%) of the 10-upside were +0.06% (FIXX) to +2.67% (MESO) while the 24-downside ranged from -0.33% (BSTG) to -6.88% (EDIT); 

 

Hammered in today’s market:

  • Alnylam Pharmaceuticals (ALNY), ReNeuron (RENE.L), Ultragenyx (RARE), Editas Medicine (EDIT), Global Blood Therapeutics (GBT) to name 5 of the 10 declining of the 35 covered

Jumping with share pricing momentum:

  • Sage Therapeutics (SAGE), BioLife Solutions (BLFS), Brainstorm Cell Therapeutics (BCLI), Mesoblast (MESO), MiMedx (OTC Pink sheets: MDXG) to name 5 of the 24 trading up of 35 covered

 

The iShares NASDAQ Biotechnology (IBB) and the SPDR S&P ETF (XBI) indicators:

  • Tuesday, the IBB closed down -2.29% and XBI also closed down -2.08%
  • Monday, the IBB closed up +1.28% and XBI also closed up +1.36%

 

Tuesday’s (10 of 10 incliners:

  • Sage Therapeutics (SAGE +$0.87 after Monday’s +$1.23);
  • BioLife Solutions (BLFS +$0.42 after Monday’s +$1.45);
  • Mesoblast (MESO +$0.32);
  • AxoGen (AXGN +$0.19 after Monday’s -$0.11);
  • Brainstorm Cell Therapeutics (BCLI +$0.07 after Monday’s +$0.89);
  • MiMedx (OTS Pink sheets: MDXG +$0.06);
  • Solid Biosciences (SLDB +$0.05 after Monday’s -$0.09);
  • Bellicum Pharmaceuticals (BLCM +$0.04 after Monday’s -$0.05);
  • Caladrius Biosciences (CLBS +$0.03);
  • Homology Medicine (FIXX +$0.01 after Monday’s +$1.23);

Tuesday’s (10 of 24) decliners:

  • Alnylam Pharmaceuticals (ALNY -$7.46 after Monday’s +$7.13 and Friday’s +$2.33);
  • ReNeuron (RENE.L -$4.25 after Monday’s +$2.50 and Friday’s-$3.25);
  • Ultragenyx (RARE -$3.61 after Monday’s +$2.03 and Friday’s +$0.89);
  • Editas Medicine (EDIT -$2.24);
  • Global Blood Therapeutics (GBT -$2.08 after Monday’s -$0.29);
  • CRISPR Therapeutics (CRSP -$1.75 after Monday’s +$2.95);
  • Regenxbio (RGNX -$1.72 after Monday’s -$0.37);
  • bluebird bio (BLUE -$1.61 after Monday’s +$1.31);
  • Fate Therapeutics (FATE -$1.11);
  • Ionis Pharmaceuticals (IONS -$1.02 after Monday’s -$0.08);

Closing flat: 1 - Stemline Therapeutics (STML – being acquired)

 

Percentage (%) movement/range statistics: look closely … notice percentage (%) movements are declining

  • Tuesday’s percentage (%) of the 10-upside were +0.06% (FIXX) to +2.67% (MESO) while the 24-downside ranged from -0.33% (BSTG) to -6.88% (EDIT); 
  • Monday’s percentage (%) of the 24-upside were +0.23% (VYGR) to +8.07% (FIXX) while the 10-downside ranged from -0.13% (IONS) to -4.98% (ADVM); 
  • Friday’s percentage (%) of the 24-upside were +0.06% (EDIT) to +9.58% (BLCM) while the 9-downside ranged from -0.06% (VCEL) to -3.83% (PSTI); 

 

Sentiment and a few daily indicators:

Sentiment was also lifted Tuesday after the European Commission, the European Union’s executive arm, agreed to a 750-billion-euro stimulus package. The stimulus is designed to help countries and sectors in the region most affected by the coronavirus pandemic. <CNBC>

While in the U.S., traders and investors are monitoring the talks in Washington on the next coronavirus relief bill.

  • Tuesday 3.85 million cases
  • Monday 3.77 million cases
  • Friday’s 3.57 cases

Tuesday’s death rate totaled 141,118 after Monday’s 140,563, Friday’s 138,000, Thursday’s 137,846, Wednesday’s 136,400 and last Tuesday’s 135,900 <Johns Hopkins University>

 

Upside volume stats: 

  • Tuesday: 6 out of the 10-upside had higher than the 3-month average volume;
  • Monday: 6 out of the 24-upside had higher than the 3-month average volume;
  • Friday: 5 out of the 24-upside had higher than the 3-month average volume;

The CBOE Volatility Index (VVIX: INDEX) tracked:

  • Tuesday was up +0.38 points or +1.55% at 24.84
  • Monday was down -1.22 points or -4.75% at 24.46
  • Friday was down -2.32 points or -8.29% at 25.68

Downside volume stats:

  • Tuesday: 4 out of the 24-downside had higher than the 3-month average volume;
  • Monday: 0 out of the 10-downside had higher than the 3-month average volume;
  • Friday: 2 out of the 9-downside had higher than the 3-month average volume;

 

July

Tuesday closed negative with 10 advancers, 24 decliners and 1 flat

Monday (7/20) closed positive with 24 advancers, 10 decliners and 1 flat

Friday closed positive with 24 advancers, 9 decliners and 2 flats

Thursday closed negative with 7 advancers, 25 decliners and 3 flats

Wednesday closed positive with 30 advancers, 4 decliners and 1 flat

Tuesday closed positive with 25 advancers, 8 decliners and 2 flats

Monday (7/13) closed negative with 4 advancers, 29 decliners and 2 flats

Friday closed negative with 9 advancers, 22 decliners and 4 flats

Thursday closed negative with 10 advancers, 24 decliners and 1 flat

Wednesday closed positive with 28 advancers, 5 decliners and 2 flats

Tuesday closed positive with 18 advancers, 12 decliners and 5 flats

Monday (7/6) closed positive with 19 advancers, 15 decliners and 1 flat

Friday was a market holiday;

Thursday closed positive with 18 advancers, 14 decliners and 3 flats

Wednesday (7/1) closed positive with 24 advancers, 7 decliners and 4 flats

 

The Bottom line:  Another, I told or wrote you so … about today’s session.

RegMed Investors’ (RMi) pre-open: bubble or the stubble https://www.regmedinvestors.com/articles/11465.

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.